Cargando…

Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease

BACKGROUND: Nonsteroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (N-ERD) comprises the triad of chronic rhinosinusitis with nasal polyps, asthma and intolerance to NSAIDs. Dupilumab treatment, targeting the interleukin-4 (IL-4) receptor α, significantly reduces polyp burden as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schneider, Sven, Poglitsch, Katharina, Morgenstern, Christina, Quint, Tamara, Gangl, Katharina, Sinz, Christoph, Bartosik, Tina, Campion, Nicholas James, Liu, David Tianxiang, Landegger, Lukas David, Tu, Aldine, Stanek, Victoria, Rocha-Hasler, Marianne, Bangert, Christine, Eckl-Dorna, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017890/ https://www.ncbi.nlm.nih.gov/pubmed/36549708 http://dx.doi.org/10.1183/13993003.01335-2022

Ejemplares similares

The “real life” efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP
por: Campion, Nicholas J., et al.
Publicado: (2023)

Associations between the Quality of Life and Nasal Polyp Size in Patients Suffering from Chronic Rhinosinusitis without Nasal Polyps, with Nasal Polyps or Aspirin-Exacerbated Respiratory Disease
por: Schneider, Sven, et al.
Publicado: (2020)

Dupilumab‐induced skin‐associated side effects in patients with chronic rhinosinusitis with nasal polyposis
por: Chromy, David, et al.
Publicado: (2022)

The nasal microbiome in patients suffering from non-steroidal anti-inflammatory drugs-exacerbated respiratory disease in absence of corticosteroids
por: Bartosik, Tina J., et al.
Publicado: (2023)

Platelet-to-lymphocyte ratio might predict the response to dupilumab treatment for patients with nasal polyposis
por: Brkic, Faris F., et al.
Publicado: (2023)

Chronic rhinosinusitis symptoms differentially impact the likelihood of major depressive disorders
por: Liu, David T., et al.
Publicado: (2022)

Comprehensive Analysis of Nasal Polyps Reveals a More Pronounced Type 2 Transcriptomic Profile of Epithelial Cells and Mast Cells in Aspirin-Exacerbated Respiratory Disease
por: Bangert, Christine, et al.
Publicado: (2022)

Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
por: Sehanobish, Esha, et al.
Publicado: (2021)

Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease
por: Laidlaw, Tanya M.
Publicado: (2018)

Differences in men and women suffering from CRSwNP and AERD in quality of life
por: Bartosik, Tina J., et al.
Publicado: (2020)

Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis
por: Quint, Tamara, et al.
Publicado: (2020)

Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
por: Van Broeck, Dorien, et al.
Publicado: (2023)

Using mass cytometry for the analysis of samples of the human airways
por: Rocha-Hasler, Marianne, et al.
Publicado: (2022)

Early effects of cigarette smoke extract on human oral keratinocytes and carcinogenesis in head and neck squamous cell carcinoma
por: Foki, Elisabeth, et al.
Publicado: (2020)

A retrospective study on long-term efficacy of intranasal lysine-aspirin in controlling NSAID-exacerbated respiratory disease
por: Pendolino, Alfonso Luca, et al.
Publicado: (2021)

Tracing Human IgE B Cell Antigen Receptor-Bearing Cells With a Monoclonal Anti-Human IgE Antibody That Specifically Recognizes Non-Receptor-Bound IgE
por: Zghaebi, Mohammed, et al.
Publicado: (2021)

Investigation of the Relationship between Aspirin-Sensitivity and Poor Response to Medical Management in NSAIDs-exacerbated Respiratory Disease Patients with Sinonasal Polyposis
por: Nabavi, Mohammad, et al.
Publicado: (2023)

NSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/Salicylates
por: Suzuki, Yoshihiro, et al.
Publicado: (2010)

Potential Biomarkers for NSAID-Exacerbated Respiratory Disease
por: Park, Hanki, et al.
Publicado: (2017)

Aspirin desensitization in NSAID-exacerbated respiratory disease and its outcomes in the clinical course of asthma: A systematic review of the literature and meta-analysis
por: Eraso, Isabel, et al.
Publicado: (2021)

Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis
por: Makowska, Joanna, et al.
Publicado: (2015)

Aspirin-Exacerbated Asthma
por: Varghese, Mathew, et al.
Publicado: (2008)

One- versus 2-day aspirin desensitization in aspirin exacerbated respiratory disease: A quality improvement project
por: Gansert, Emily, et al.
Publicado: (2023)

Annual trends in Google searches provides insights related to rhinosinusitis exacerbations
por: Liu, David T., et al.
Publicado: (2021)

NSAID-exacerbated respiratory disease: a population study
por: Andersén, Heidi, et al.
Publicado: (2022)

Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthma
por: Corren, Jonathan, et al.
Publicado: (2023)

Aspirin Exacerbated Respiratory Disease
por: Teran, Luis M., et al.
Publicado: (2012)

Exacerbation of IgA nephropathy in a patient receiving dupilumab
por: Yamamoto, Masako, et al.
Publicado: (2022)

NSAIDs Naproxen, Ibuprofen, Salicylate, and Aspirin Inhibit TRPM7 Channels by Cytosolic Acidification
por: Chokshi, Rikki, et al.
Publicado: (2021)

Effect of exacerbation history on clinical response to dupilumab in moderate-to-severe uncontrolled asthma
por: Corren, Jonathan, et al.
Publicado: (2021)

Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation
por: Hanania, Nicola A, et al.
Publicado: (2022)

3437 Associations of aspirin, non-aspirin NSAIDs, statins, and metformin with risk of biliary cancer: A Swedish population-based cohort study
por: Bonilla, Lorena Marcano, et al.
Publicado: (2019)

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease
por: Miller, B, et al.
Publicado: (2013)

The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD)()
por: Spies, Jonas Willian, et al.
Publicado: (2015)

Biomarkers for predicting response to aspirin therapy in aspirin‐exacerbated respiratory disease
por: Tyrak, Katarzyna E., et al.
Publicado: (2021)

Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease
por: Garcia Cruz, Maria L., et al.
Publicado: (2012)

NSAID-Exacerbated Respiratory Disease (NERD): From Pathogenesis to Improved Care
por: Woo, Seong-Dae, et al.
Publicado: (2020)

Complementary Participation of Genetics and Epigenetics in Development of NSAID-exacerbated Respiratory Disease
por: Lee, Jong-Uk, et al.
Publicado: (2019)

Baseline Conservative and Surgical Management in the Treatment of NSAID-Exacerbated Respiratory Disease
por: Sillanpää, Saara, et al.
Publicado: (2021)

Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease
por: Howe, Rachel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ibqark7hugc559l1thosht7050